These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2511737)

  • 1. Psychopathology during long-term lithium treatment of patients with major affective disorders. A prospective study.
    Nilsson A; Axelsson R
    Acta Psychiatr Scand; 1989 Oct; 80(4):375-88. PubMed ID: 2511737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium discontinuers. I. Clinical characteristics and outcome.
    Nilsson A; Axelsson R
    Acta Psychiatr Scand; 1990 Dec; 82(6):433-8. PubMed ID: 2127155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders.
    Simhandl C; Denk E; Thau K
    J Affect Disord; 1993 Aug; 28(4):221-31. PubMed ID: 8227758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders.
    Maj M; Pirozzi R; Kemali D
    Psychopharmacology (Berl); 1989; 98(4):535-8. PubMed ID: 2505295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of valproate in primary psychiatric disorders.
    Hayes SG
    J Clin Psychiatry; 1989 Mar; 50 Suppl():35-9. PubMed ID: 2494158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with discontinuation of long-term lithium treatment.
    Nilsson A; Axelsson R
    Acta Psychiatr Scand; 1989 Sep; 80(3):221-30. PubMed ID: 2510458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and red cell folate and affective morbidity in lithium prophylaxis.
    McKeon P; Shelley R; O'Regan S; O'Broin J
    Acta Psychiatr Scand; 1991 Mar; 83(3):199-201. PubMed ID: 2031463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney functioning during lithium treatment: a prospective study of patients treated with lithium for up to ten years.
    Povlsen UJ; Hetmar O; Ladefoged J; Bolwig TG
    Acta Psychiatr Scand; 1992 Jan; 85(1):56-60. PubMed ID: 1546549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium therapy: from clinical trials to practical management.
    Coppen A; Abou-Saleh MT
    Acta Psychiatr Scand; 1988 Dec; 78(6):754-62. PubMed ID: 3146892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term treatment of bipolar disorder: how should we use lithium salts?].
    Del Grande C; Muti M; Musetti L; Pergentini I; Corsi M; Turri M; Soldani I; Corsini GU; Dell'Osso L
    Riv Psichiatr; 2012; 47(6):515-26. PubMed ID: 23160112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol changes in long-term lithium therapy.
    Smigan L; Perris C
    Neuropsychobiology; 1984; 11(4):219-23. PubMed ID: 6436729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of bipolar disorder on long-term treatment with lithium.
    O'Connell RA; Mayo JA; Flatow L; Cuthbertson B; O'Brien BE
    Br J Psychiatry; 1991 Jul; 159():123-9. PubMed ID: 1888958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of relapses in subjects with mood disorder on lithium treatment.
    Gasperini M; Scherillo P; Manfredonia MG; Franchini L; Smeraldi E
    Eur Neuropsychopharmacol; 1993 Jun; 3(2):103-10. PubMed ID: 8364346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium discontinuers. II. Therapeutic outcome.
    Nilsson A; Axelsson R
    Acta Psychiatr Scand; 1991 Jul; 84(1):78-82. PubMed ID: 1681682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of interepisode symptoms and relapse in affective disorder patients treated with lithium carbonate.
    Goodnick PJ; Fieve RR; Schlegel A; Baxter N
    Am J Psychiatry; 1987 Mar; 144(3):367-9. PubMed ID: 3103474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression.
    Kim SJ; Lee YJ; Lee YJ; Cho SJ
    J Affect Disord; 2014 Mar; 157():33-40. PubMed ID: 24581825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium prophylaxis of manic-depressive disorder: daily lithium dosing schedule versus every second day.
    Jensen HV; Plenge P; Mellerup ET; Davidsen K; Toftegaard L; Aggernaes H; Bjørum N
    Acta Psychiatr Scand; 1995 Jul; 92(1):69-74. PubMed ID: 7572251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination.
    Prien RF; Kupfer DJ; Mansky PA; Small JG; Tuason VB; Voss CB; Johnson WE
    Arch Gen Psychiatry; 1984 Nov; 41(11):1096-104. PubMed ID: 6437366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.